Compare JFU & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JFU | CPHI |
|---|---|---|
| Founded | 2006 | N/A |
| Country | China | China |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.9M | 25.3M |
| IPO Year | 2018 | 2008 |
| Metric | JFU | CPHI |
|---|---|---|
| Price | $2.25 | $0.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.9K | ★ 75.4K |
| Earning Date | 12-09-2022 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,144,268.00 |
| Revenue This Year | $4,000.66 | N/A |
| Revenue Next Year | $5.00 | N/A |
| P/E Ratio | $1.43 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.95 | $0.38 |
| 52 Week High | $9.48 | $19.19 |
| Indicator | JFU | CPHI |
|---|---|---|
| Relative Strength Index (RSI) | 34.80 | 31.33 |
| Support Level | N/A | $0.38 |
| Resistance Level | $2.97 | $0.68 |
| Average True Range (ATR) | 0.29 | 0.06 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 11.63 | 16.34 |
9F Inc is a digital technology and wealth management service provider aiming to empower institutional partners with financial technologies as well as attract investors with investment opportunities that come with the vast potential of China's new consumer economy and the appreciation of world-wide assets and access to quality products at a competitive price. The Company's operations are organized into segments, consisting of E-commerce services, technology Empowerment service, and Wealth Management services.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.